Prism’s clinical development services extend from Phase I study design to post marketing study support activities. We have developed a flexible yet structured process that allows us to work at different levels alongside our client organisations. A major advantage of this approach is that Prism can match resources to projects as they evolve. This might include leading the development of clinical plans, facilitating their implementation or providing medical oversight of their delivery.

 Prism undertook an extensive review of the scientific literature, including congress subtracts, to identify all
possible therapeutic applications of the new product.

Development of a Strategic Medical Plan
for a new molecule

 The Prism approach has helped not only to facilitate the meetings themselves, but also to sustain the highest standards.

Editorial Support for Drug Safety Monitoring Boards 

Prism’s principle motivation is to develop programmes and individual activities that have future clinical relevance and thereby will address the business needs of our clients. We have built our team with colleagues who can draw upon their experience and acumen to look beyond the direct scope of work, identify and proactively address the issues. Our focus is always scientific quality. Our downstream clinical services only relate to data evaluation, ensuring that there is no conflict between our recommendations and service offerings.


Prism’s clients include pharmaceutical and diagnostics companies, both large and small. We have worked to  successfully optimise the design of individual studies as well as full clinical programmes.

Liaison with our scientific writing teams provides a link between research and medical education, which thrives upon our interactions with academic leaders. Our clinical development and medical affairs specialists bring both therapeutic area and functional area expertise.


 The rapid, yet thorough medical review of 100% of cases ensured that as complete an information picture as possible was available for the sponsor to meet its database lock goals.

Development of a Clinical Science Review